Bleich M - Search Results

1

Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats.

Schäfer S, Linz W, Bube A, Gerl M, Huber J, Kürzel GU, Bleich M, Schmidts HL, Busch AE, Rütten H. Schäfer S, et al. Among authors: bleich m. Cardiovasc Res. 2003 Nov 1;60(2):447-54. doi: 10.1016/s0008-6363(03)00544-3. Cardiovasc Res. 2003. PMID: 14613875

2

Chronic vasopeptidase inhibition normalizes diabetic endothelial dysfunction.

Schäfer S, Steioff K, Linz W, Bleich M, Busch AE, Löhn M. Schäfer S, et al. Among authors: bleich m. Eur J Pharmacol. 2004 Jan 26;484(2-3):361-2. doi: 10.1016/j.ejphar.2003.11.008. Eur J Pharmacol. 2004. PMID: 14744624

3

Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent.

Schäfer S, Schmidts HL, Bleich M, Busch AE, Linz W. Schäfer S, et al. Among authors: bleich m. Br J Pharmacol. 2004 Sep;143(1):27-32. doi: 10.1038/sj.bjp.0705884. Epub 2004 Aug 2. Br J Pharmacol. 2004. PMID: 15289289 Free PMC article.

4

The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy.

Schäfer S, Linz W, Vollert H, Biemer-Daub G, Rütten H, Bleich M, Busch AE. Schäfer S, et al. Among authors: bleich m. Diabetologia. 2004 Jan;47(1):98-103. doi: 10.1007/s00125-003-1264-8. Epub 2003 Nov 14. Diabetologia. 2004. PMID: 14618238

5

Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.

Wihler C, Schäfer S, Schmid K, Deemer EK, Münch G, Bleich M, Busch AE, Dingermann T, Somoza V, Baynes JW, Huber J. Wihler C, et al. Among authors: bleich m. Diabetologia. 2005 Aug;48(8):1645-53. doi: 10.1007/s00125-005-1837-9. Epub 2005 Jul 12. Diabetologia. 2005. PMID: 16010524

6

Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.

Wirth KJ, Paehler T, Rosenstein B, Knobloch K, Maier T, Frenzel J, Brendel J, Busch AE, Bleich M. Wirth KJ, et al. Among authors: bleich m. Cardiovasc Res. 2003 Nov 1;60(2):298-306. doi: 10.1016/s0008-6363(03)00543-1. Cardiovasc Res. 2003. PMID: 14613859

7

Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.

Knobloch K, Brendel J, Rosenstein B, Bleich M, Busch AE, Wirth KJ. Knobloch K, et al. Among authors: bleich m. Med Sci Monit. 2004 Jul;10(7):BR221-8. Epub 2004 Jun 29. Med Sci Monit. 2004. PMID: 15232496

8

Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.

Löhn M, Steioff K, Bleich M, Busch AE, Ivashchenko Y. Löhn M, et al. Among authors: bleich m. Eur J Pharmacol. 2005 Jan 10;507(1-3):179-86. doi: 10.1016/j.ejphar.2004.11.047. Epub 2004 Dec 31. Eur J Pharmacol. 2005. PMID: 15659308

9

Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.

Weyermann A, Vollert H, Busch AE, Bleich M, Gögelein H. Weyermann A, et al. Among authors: bleich m. Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr;369(4):374-81. doi: 10.1007/s00210-004-0882-0. Epub 2004 Mar 16. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15024553

10

Synthesis and activity of novel and selective I(Ks)-channel blockers.

Gerlach U, Brendel J, Lang HJ, Paulus EF, Weidmann K, Brüggemann A, Busch AE, Suessbrich H, Bleich M, Greger R. Gerlach U, et al. Among authors: bleich m. J Med Chem. 2001 Nov 8;44(23):3831-7. doi: 10.1021/jm0109255. J Med Chem. 2001. PMID: 11689069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters